CD34 and acute lymphoblastic leukemia: In this work, we employed a Markov chain mathematical model to quantify the rates of cell state transitions between CD34+/CD38−, CD34+/CD38+, CD34−/CD38+, and CD34−/CD38− leukemia subpopulations in patients with B-ALL.